- Home
- ANL vs ERH Comparison
ANL vs ERH Comparison
Compare ANL & ERH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ANL
- ERH
- Stock Information
- Founded
- ANL 2004
- ERH 2004
- Country
- ANL Cayman Islands
- ERH United States
- Employees
- ANL 127
- ERH N/A
- Industry
- ANL
- ERH Finance/Investors Services
- Sector
- ANL
- ERH Finance
- Exchange
- ANL Nasdaq
- ERH Nasdaq
- Market Cap
- ANL 115.1M
- ERH 97.6M
- IPO Year
- ANL 2023
- ERH N/A
- Fundamental
- Price
- ANL $3.12
- ERH $10.75
- Analyst Decision
- ANL Strong Buy
- ERH
- Analyst Count
- ANL 2
- ERH 0
- Target Price
- ANL $9.00
- ERH N/A
- AVG Volume (30 Days)
- ANL 29.1K
- ERH 23.2K
- Earning Date
- ANL 08-08-2024
- ERH 01-01-0001
- Dividend Yield
- ANL N/A
- ERH 8.85%
- EPS Growth
- ANL N/A
- ERH N/A
- EPS
- ANL N/A
- ERH N/A
- Revenue
- ANL $5,000,000.00
- ERH N/A
- Revenue This Year
- ANL N/A
- ERH N/A
- Revenue Next Year
- ANL N/A
- ERH N/A
- P/E Ratio
- ANL N/A
- ERH N/A
- Revenue Growth
- ANL N/A
- ERH N/A
- 52 Week Low
- ANL $1.85
- ERH $7.97
- 52 Week High
- ANL $17.48
- ERH $10.91
- Technical
- Relative Strength Index (RSI)
- ANL 64.09
- ERH 43.32
- Support Level
- ANL $2.88
- ERH $11.10
- Resistance Level
- ANL $3.50
- ERH $10.80
- Average True Range (ATR)
- ANL 0.41
- ERH 0.14
- MACD
- ANL 0.12
- ERH -0.02
- Stochastic Oscillator
- ANL 60.19
- ERH 26.16
About ANL Adlai Nortye Ltd.
Adlai Nortye Ltd is a clinical-stage biotechnology company focused on the discovery and development of cancer therapies for patients across the spectrum of tumor types. The company has a robust pipeline of drug candidates which includes buparlisib (AN2025), palupiprant (AN0025), and AN4005 in the clinical stage, and AN8025, AN9025, and AN1025 in the preclinical stage.
About ERH Allspring Utilities and High Income Fund
Allspring Utilities and High Income Fund is a diversified closed-end management investment company. Its investment objective is to seek a high level of current income and moderate capital growth, with an emphasis on providing tax-advantaged dividend income. The company allocates a majority of its total assets to a sleeve that places a focus on common, preferred, and convertible preferred stocks of utility companies and the rest of its total assets to a sleeve of U.S. dollar denominated below investment grade (high yield) debt.